StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
113
This year
8
Publishing Date
2023 - 09 - 07
3
2023 - 05 - 31
2
2023 - 02 - 08
2
2023 - 02 - 06
2
2022 - 12 - 01
1
2022 - 10 - 21
1
2022 - 10 - 17
1
2022 - 10 - 11
1
2022 - 09 - 14
2
2022 - 09 - 13
2
2022 - 09 - 08
1
2022 - 08 - 23
1
2022 - 08 - 04
1
2022 - 08 - 02
1
2022 - 07 - 25
1
2022 - 07 - 11
1
2022 - 06 - 27
1
2022 - 06 - 09
1
2022 - 05 - 31
1
2022 - 05 - 06
1
2022 - 05 - 05
1
2022 - 04 - 25
1
2022 - 04 - 19
1
2022 - 04 - 13
1
2022 - 04 - 11
1
2022 - 04 - 04
1
2022 - 03 - 21
1
2022 - 03 - 18
1
2022 - 03 - 14
1
2022 - 02 - 28
1
2022 - 02 - 24
1
2022 - 01 - 04
2
2021 - 12 - 29
1
2021 - 12 - 20
1
2021 - 12 - 16
1
2021 - 12 - 07
1
2021 - 11 - 23
1
2021 - 10 - 15
1
2021 - 10 - 11
1
2021 - 10 - 05
1
2021 - 09 - 30
1
2021 - 09 - 13
1
2021 - 07 - 30
1
2021 - 07 - 22
1
2021 - 06 - 29
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 02
1
2021 - 05 - 19
1
2021 - 05 - 18
2
2021 - 05 - 14
1
2021 - 03 - 17
1
2021 - 03 - 10
1
2021 - 02 - 08
1
2021 - 01 - 29
1
2021 - 01 - 04
1
2020 - 12 - 29
1
2020 - 12 - 08
1
2020 - 12 - 07
1
2020 - 12 - 01
1
Sector
Electronic technology
1
Finance
3
Health services
12
Health technology
97
Manufacturing
1
Non-energy minerals
1
Tags
Alliances
3
Alzheimer’s
3
Application
6
Approval
6
Asia
3
Biocapital
3
Biopharma
6
Biotech-beach
4
Blood
3
Buntanetap
3
Bx004
11
Cancer
12
Cel
3
Clinical-trials-phase-iii
3
Conference
6
Covid
4
Cystic fibrosis
3
Designation
4
Disease
25
Drug
8
Eczema
3
Ema
3
Events
7
Fda
9
Fibrosis
11
Global
5
Heart
3
Infections
13
International
3
Iot
5
Liver
5
Mat2203
5
Multikine
3
N/a
49
Namodenoson
6
Ongoing
5
Osteoarthritis
3
Pancreatic
4
Parkinson's
3
Patent
14
Pharm-country
5
Phase 2
4
Piclidenoson
6
Positive
10
Preclinical
5
Product-news
3
Prx-102
4
Prx012
5
Psoriasis
4
Qvc
3
Rare
10
Research
22
Results
5
Study
14
Submission
3
Technology
4
Therapy
6
Topline
4
Treatment
112
Trial
17
Entities
Abbott laboratories
1
Actinium pharmaceuticals, inc.
3
American shared hospital services
1
Ampio pharmaceuticals, inc.
2
Annovis bio, inc.
11
Biomx inc.
14
Can-fite biopharma ltd
15
Cel-sci corporation
4
Daxor corporation
4
Electromed, inc.
1
Ibio, inc.
2
India globalization capital inc.
2
Inspiremd inc.
1
Lineage cell therapeutics, inc.
10
Matinas biopharma holdings, inc.
5
Medtronic plc
1
Nanoviricides, inc.
2
Navidea biopharmaceuticals, inc.
2
Novabay pharmaceuticals, inc.
3
Oncocyte corporation
2
Palatin technologies, inc.
7
Power reit
2
Protalix biotherapeutics, inc.
11
Senseonics holdings, inc.
1
Signature bank
1
Silvercorp metals inc.
1
Stereotaxis, inc.
3
Terumo corp
1
Timber pharmaceuticals, inc.
2
Volitionrx limited
2
Xenetic biosciences, inc.
1
Symbols
ABT
1
AMPE
2
AMS
1
ANVS
11
ATNM
3
CANF
15
CVM
4
DXR
4
ELMD
1
IBIO
2
IGC
2
LCTX
10
MDT
1
MTNB
5
NAVB
2
NBY
3
NNVC
2
NSPR
1
OCX
2
PHGE
14
PLX
11
PTN
7
PW
2
SBNY
1
SENS
1
STXS
3
SVM
1
TMBR
2
TRUMF
1
TRUMY
1
VNRX
2
XBIO
1
Exchanges
Amex
113
Nasdaq
4610
Nyse
1342
Crawled Date
2023 - 09 - 07
3
2023 - 05 - 31
2
2023 - 02 - 08
2
2023 - 02 - 06
2
2022 - 12 - 01
1
2022 - 10 - 21
1
2022 - 10 - 17
1
2022 - 10 - 11
1
2022 - 09 - 14
2
2022 - 09 - 13
2
2022 - 09 - 08
1
2022 - 08 - 23
1
2022 - 08 - 04
1
2022 - 08 - 02
1
2022 - 07 - 25
1
2022 - 07 - 11
1
2022 - 06 - 27
1
2022 - 06 - 09
1
2022 - 05 - 31
1
2022 - 05 - 06
1
2022 - 05 - 05
1
2022 - 04 - 25
1
2022 - 04 - 19
1
2022 - 04 - 13
1
2022 - 04 - 11
1
2022 - 04 - 04
1
2022 - 03 - 21
1
2022 - 03 - 18
1
2022 - 03 - 14
1
2022 - 02 - 28
1
2022 - 02 - 24
1
2022 - 01 - 04
2
2021 - 12 - 29
1
2021 - 12 - 20
1
2021 - 12 - 16
1
2021 - 12 - 07
1
2021 - 11 - 23
1
2021 - 10 - 15
1
2021 - 10 - 11
1
2021 - 10 - 05
1
2021 - 09 - 30
1
2021 - 09 - 13
1
2021 - 07 - 30
1
2021 - 07 - 22
1
2021 - 06 - 29
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 02
1
2021 - 05 - 19
1
2021 - 05 - 18
2
2021 - 05 - 14
1
2021 - 03 - 17
1
2021 - 03 - 10
1
2021 - 02 - 08
1
2021 - 01 - 29
1
2021 - 01 - 04
1
2020 - 12 - 29
1
2020 - 12 - 08
1
2020 - 12 - 07
1
2020 - 12 - 01
1
Crawled Time
04:20
1
07:00
1
09:00
1
10:00
1
11:00
10
12:00
20
12:15
3
12:20
2
12:30
6
13:00
23
13:20
4
13:30
6
14:00
9
14:15
1
14:20
2
14:30
1
15:00
2
15:20
1
16:00
3
17:00
3
18:02
1
19:01
1
20:00
3
21:00
1
21:06
1
22:00
3
22:01
1
23:00
2
Source
www.biospace.com
63
www.daxor.com
1
www.electromed.com
1
www.globenewswire.com
24
www.igcinc.us
2
www.prnewswire.com
22
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
treatment
exchanges :
Amex
save search
Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference
Published:
2024-03-11
(Crawled : 12:30)
- biospace.com/
CANF
|
$2.02
3.06%
-2.48%
10K
|
Health Technology
|
-10.86%
|
O:
-0.45%
H:
2.27%
C:
2.27%
europe
liver
conference
distribution
pancreatic
treatment
namodenoson
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
Published:
2024-03-08
(Crawled : 15:00)
- biospace.com/
SENS
|
$0.416
3.43%
0.7%
2.2M
|
Electronic Technology
|
-28.95%
|
O:
1.51%
H:
6.65%
C:
4.18%
eversense
conference
approval
international
advanced
diabetes
study
Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis
Published:
2024-02-20
(Crawled : 12:30)
- globenewswire.com
MTNB
|
$0.19
-1.04%
0.0%
960K
|
Health Technology
|
-17.39%
|
O:
4.35%
H:
11.21%
C:
-0.46%
mat2203
fda
treatment
biopharma
trial
agreement
NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon
Published:
2024-02-15
(Crawled : 13:00)
- biospace.com/
NNVC
|
$1.175
1.29%
0.0%
13K
|
Health Technology
|
-0.85%
|
O:
2.56%
H:
0.83%
C:
-0.83%
nv-387
covid
report
treatment
trial
Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
Published:
2024-02-13
(Crawled : 14:00)
- biospace.com/
LCTX
|
$1.2
-6.98%
0.0%
1M
|
Health Technology
|
19.44%
|
O:
1.85%
H:
0.83%
C:
-7.27%
fda
cell
treatment
clearance
Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s Portfolio
Published:
2024-01-30
(Crawled : 13:00)
- globenewswire.com
ANVS
|
$9.85
9.57%
0.96%
240K
|
Health Technology
|
-13.44%
|
O:
5.45%
H:
0.0%
C:
-10.42%
patent
treatment
application
DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES
Published:
2024-01-09
(Crawled : 13:00)
- globenewswire.com
DXR
|
$9.6135
0.73%
700
|
Health Technology
|
-2.39%
|
O:
-0.98%
H:
0.75%
C:
-0.1%
patent
treatment
blood
smart
technology
BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis
Published:
2024-01-04
(Crawled : 13:00)
- globenewswire.com
PHGE
|
News
|
$0.2937
4.86%
0.1%
110K
|
Health Technology
|
3.32%
|
O:
-0.37%
H:
6.26%
C:
0.04%
bx004
drug
food
infection
treatment
fibrosis
designation
Lineage Announces Submission of OPC1 Investigational New Drug Amendment for Treatment of Chronic and Subacute Spinal Cord Injury
Published:
2023-12-18
(Crawled : 14:00)
- biospace.com/
LCTX
|
$1.2
-6.98%
0.0%
1M
|
Health Technology
|
41.74%
|
O:
1.66%
H:
17.81%
C:
14.57%
drug
treatment
submission
Can-Fite’s Namodenoson for the Treatment of Pancreatic Cancer Patients: Progress in Clinical Development
Published:
2023-12-04
(Crawled : 13:30)
- biospace.com/
CANF
|
$2.02
3.06%
-2.48%
10K
|
Health Technology
|
-19.26%
|
O:
0.0%
H:
1.23%
C:
-4.92%
cancer
pancreatic
treatment
namodenoson
BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis
Published:
2023-11-29
(Crawled : 12:00)
- globenewswire.com
PHGE
|
News
|
$0.2937
4.86%
0.1%
110K
|
Health Technology
|
-50.0%
|
O:
-30.36%
H:
14.21%
C:
-23.08%
bx004
positive
treatment
fibrosis
topline
infections
trial
results
Actinium Announces Oral Presentation at ASH Annual Meeting Highlighting Iomab-B Treatment Significantly Increased Median Overall Survival in Relapsed or Refractory AML Patients with Highly Unfavorable TP53 Gene Mutation in the Phase 3 SIERRA Trial
Published:
2023-11-02
(Crawled : 13:00)
- prnewswire.com
ATNM
|
$6.67
-8.0%
1.2%
420K
|
Health Technology
|
23.06%
|
O:
1.29%
H:
3.83%
C:
-16.58%
tp53
presentation
treatment
aml
meeting
trial
BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the 37th Annual North American Cystic Fibrosis Conference
Published:
2023-10-27
(Crawled : 12:00)
- globenewswire.com
PHGE
|
News
|
$0.2937
4.86%
0.1%
110K
|
Health Technology
|
3.67%
|
O:
11.07%
H:
0.0%
C:
-8.33%
bx004
conference
treatment
ongoing
fibrosis
infections
study
Palatin Presents Data at the United European Gastroenterology Week 2023 Conference On PL8177 Ulcerative Colitis Treatment
Published:
2023-10-16
(Crawled : 20:00)
- biospace.com/
PTN
|
$1.89
-0.53%
0.0%
180K
|
Health Technology
|
9.83%
|
O:
0.58%
H:
5.75%
C:
0.57%
pl8177
conference
treatment
week
Expert Panelists Advocate Use of Daxor’s Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific Meeting
Published:
2023-10-13
(Crawled : 12:00)
- globenewswire.com
DXR
|
$9.6135
0.73%
700
|
Health Technology
|
7.21%
|
O:
0.0%
H:
0.0%
C:
-1.11%
america
treatment
meeting
heart
technology
CEL-SCI Files Request With the UK’s MHRA Regarding Path to Approval for Multikine in the Treatment of Head & Neck Cancer
Published:
2023-10-05
(Crawled : 13:30)
- biospace.com/
CVM
|
$1.5
1.33%
160K
|
Health Technology
|
31.03%
|
O:
0.86%
H:
4.26%
C:
-6.84%
multikine
approval
cancer
treatment
BiomX Announces Completion of Patient Dosing in Part 2 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis
Published:
2023-10-04
(Crawled : 11:00)
- globenewswire.com
PHGE
|
News
|
$0.2937
4.86%
0.1%
110K
|
Health Technology
|
-20.0%
|
O:
2.86%
H:
0.0%
C:
-0.03%
bx004
treatment
fibrosis
infections
study
Can-Fite Novel Approach for the Treatment of Pancreatic Carcinoma with Namodenoson Receives Appreciation of the American Association of Cancer Research (AACR)
Published:
2023-09-27
(Crawled : 13:00)
- biospace.com/
CANF
|
$2.02
3.06%
-2.48%
10K
|
Health Technology
|
-23.94%
|
O:
5.79%
H:
1.82%
C:
-8.76%
association
cancer
pancreatic
treatment
namodenoson
research
Flow Diversion Aneurysm Treatment Market to grow by USD 2.11 billion from 2022 to 2027, North America to account for 38% of market growth - Technavio
Published:
2023-09-24
(Crawled : 04:20)
- prnewswire.com
MDT
|
$79.19
0.14%
0.0%
6.1M
|
Health Technology
|
Email alert
Add to watchlist
TRUMY
|
$16.69
0.79%
54K
|
Manufacturing
|
Email alert
Add to watchlist
TRUMF
|
$17.112
-17.59%
1.5K
|
Health Technology
|
Email alert
Add to watchlist
NSPR
4
|
$2.21
-1.81%
14K
|
Health Technology
|
Email alert
Add to watchlist
america
treatment
flow
growth
market
Palatin Completes Enrollment in Phase 3 MELODY-1 Study of PL9643 For the Treatment of Patients with Dry Eye Disease
Published:
2023-09-07
(Crawled : 22:00)
- biospace.com/
PTN
|
$1.89
-0.53%
0.0%
180K
|
Health Technology
|
-16.67%
|
O:
0.43%
H:
3.49%
C:
-2.18%
pl9643
disease
treatment
eye
study
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.